1 recruiting, 1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Jordan Kharofa: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Promoting Immunotherapy Efficacy With Low-Dose Liver RT LD-LRT - Low-Dose Liver Radiation (LD-LRT), Non Small Cell Lung Cancer | Not applicable | Recruiting | Jordan Kharofa | 21 | 2025-12-15 | 2026-02-27 |
| Neoadjuvant Therapy in Biliary Adenocarcinoma Gemcitabine, Cisplatin, Fluorouracil - Cholangiocarcinoma, Biliary Cancer | Phase 1 | Withdrawn | Jordan Kharofa | 2021-02-04 | 2022-04-20 | |
| Proton Therapy in Reducing Toxicity in Anal Cancer Proton therapy, Chemotherapy - Anus Neoplasms | Phase 2 | Unknown | Jordan Kharofa | 14 | 2017-01-04 | 2024-09-19 |
Anus Neoplasms (1) · Biliary Tract Neoplasms (1) · Carcinoma, Non-Small-Cell Lung (1) · Cholangiocarcinoma (1) · Melanoma (1)
Fluorouracil (2) · Cisplatin (1) · Drug Therapy (1) · Gemcitabine (1) · Mitomycin (1) · Proton Therapy (1)
United States (3)